Single-dose (30 mg/kg) azithromycin compared with 10-day amoxicillin/clavulanate for the treatment of uncomplicated acute otitis media: a double-blind, placebo-controlled, randomized clinical trial()

Background: The long half-life of azithromycin allows for single-dose oral therapy for acute otitis media (AOM). Objective: This study was designed to compare the efficacy and tolerability of single-dose azithromycin with 10-day, twice-daily amoxicillin/clavulanate for the treatment of new-onset, un...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Block, Stan L, Arrieta, Antonio, Seibel, Matthew, McLinn, Samuel, Eppes, Stephen, Murphy, Mary J
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2003
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4061968/
https://ncbi.nlm.nih.gov/pubmed/24944351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2003.09.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky